Excel-tech Ltd.

Excel-tech Ltd.

September 28, 2007 11:23 ET

XLTEK: Re-Filing of Annual Certificates for Year Ended January 31, 2007 and Interim Certificates for Quarters Ending April 30, 2007 and July 31, 2007

OAKVILLE, ONTARIO--(Marketwire - Sept. 28, 2007) - Excel-Tech Ltd. ("XLTEK") (TSX:NRV) a medical technology company that designs, develops and sells proprietary neurodiagnostic and sleep therapy devices, announced today that at the request of the Ontario Securities Commission it has filed amended certifications of the President and CEO and Chief Financial Officer in respect of its Annual Filing, Form 52-109F1 for the year ended January 31, 2007 and amended certifications in respect of its Interim Filings, Form 52-109F2 for the quarters ending April 30, 2007 and July 31, 2007. The re-filing of the certificates was necessary due to the use of out-dated forms in the previously filed certificates.


Excel-Tech Ltd. ("XLTEK") is a medical technology company that designs, develops and sells proprietary neurodiagnostic and sleep therapy devices. XLTEK's Advanced Neuro-Diagnostic Instruments are used by neurology specialists at leading hospitals in the US to assist in the diagnosis and monitoring of epilepsy, peripheral nerve and sleep disorders and the monitoring of the nervous system during surgery. XLTEK's new SleepRite continuous positive airway pressure device measures both the compliance and the effectiveness of therapy for patients with obstructive sleep apnea. XLTEK is headquartered in Oakville, Ontario, Canada. The Company's common shares trade on the Toronto Stock Exchange (Symbol: NRV.TO). Additional information about XLTEK and its products may be found at www.xltek.com.

Forward-Looking Statements:

Certain statements contained in this release containing words like "believe", "intend", "may", "expect" and other similar expressions, are forward-looking statements that involve a number of risks and uncertainties. Factors that could cause actual results to differ materially from those projected in the Company's forward-looking statements include the following: market acceptance of our technologies and products; our ability to obtain financing; our financial and technical resources relative to those of our competitors; our ability to keep up with rapid technological change; government regulation of our technologies; our ability to enforce our intellectual property rights and protect our proprietary technologies; the ability to obtain and develop partnership opportunities; the timing of commercial product launches; the ability to achieve key technical milestones in key products and other risk factors identified from time to time in the Company's filings.

Contact Information